These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 28736372)

  • 1. [Clinical value of apolipoprotein B versus low-density lipoprotein cholesterol in assessing risks of coronary artery disease].
    Chen S; Zhao JZ; Hu J; Guo ZG
    Nan Fang Yi Ke Da Xue Xue Bao; 2017 Jul; 37(7):938-942. PubMed ID: 28736372
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Study on the correlation between subgroup of blood lipid with degree of coronary artery stenosis in patients with coronary atherosclerotic heart disease].
    Wang XY; Peng YJ; Han XJ; Jia KG
    Zhonghua Yu Fang Yi Xue Za Zhi; 2021 Dec; 55(12):1435-1441. PubMed ID: 34963240
    [No Abstract]   [Full Text] [Related]  

  • 3. [Relationship between serum levels of osteoproteins, inflammatory cytokines and coronary heart disease and disease severity].
    Zhao F; Zhang R; Zhao H; Liu T; Ren M; Song Y; Liu S; Cong H
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2019 May; 31(5):588-593. PubMed ID: 31198145
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The association between serum apolipoprotein A-I and apolipoprotein B and the severity of angiographical coronary artery disease.
    Khadem-Ansari MH; Rasmi Y; Rahimi-Pour A; Jafarzadeh M
    Singapore Med J; 2009 Jun; 50(6):610-3. PubMed ID: 19551315
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Apolipoprotein B improves risk assessment of future coronary heart disease in the Framingham Heart Study beyond LDL-C and non-HDL-C.
    Pencina MJ; D'Agostino RB; Zdrojewski T; Williams K; Thanassoulis G; Furberg CD; Peterson ED; Vasan RS; Sniderman AD
    Eur J Prev Cardiol; 2015 Oct; 22(10):1321-7. PubMed ID: 25633587
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association Between Serum LDL-C and ApoB and SYNTAX Score in Patients With Stable Coronary Artery Disease.
    Lin T; Wang L; Guo J; Liu P; Chen L; Wei M; Li G
    Angiology; 2018 Sep; 69(8):724-729. PubMed ID: 29310455
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Apolipoprotein B/apolipoprotein A1 ratio and non-high-density lipoprotein cholesterol. Predictive value for CHD severity and prognostic utility in CHD patients.
    Liting P; Guoping L; Zhenyue C
    Herz; 2015 Mar; 40 Suppl 1():1-7. PubMed ID: 25374385
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Apolipoprotein B and coronary artery disease in women: a cross-sectional study in women undergoing their first coronary angiography.
    Westerveld HT; van Lennep JE; van Lennep HW; Liem AH; de Boo JA; van der Schouw YT; Erkelens DW
    Arterioscler Thromb Vasc Biol; 1998 Jul; 18(7):1101-7. PubMed ID: 9672070
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Implications of Total to High-Density Lipoprotein Cholesterol Ratio Discordance With Alternative Lipid Parameters for Coronary Atheroma Progression and Cardiovascular Events.
    Elshazly MB; Nicholls SJ; Nissen SE; St John J; Martin SS; Jones SR; Quispe R; Stegman B; Kapadia SR; Tuzcu EM; Puri R
    Am J Cardiol; 2016 Sep; 118(5):647-55. PubMed ID: 27392507
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The ratio of apoB/apoAI, apoB and lipoprotein(a) are the best predictors of stable coronary artery disease.
    Rasouli M; Kiasari AM; Mokhberi V
    Clin Chem Lab Med; 2006; 44(8):1015-21. PubMed ID: 16879071
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of Novel Low-Density Lipoprotein-Cholesterol Assessment on the Utility of Secondary Non-High-Density Lipoprotein-C and Apolipoprotein B Targets in Selected Worldwide Dyslipidemia Guidelines.
    Sathiyakumar V; Park J; Quispe R; Elshazly MB; Michos ED; Banach M; Toth PP; Whelton SP; Blumenthal RS; Jones SR; Martin SS
    Circulation; 2018 Jul; 138(3):244-254. PubMed ID: 29506984
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Residual dyslipidemia according to low-density lipoprotein cholesterol, non-high-density lipoprotein cholesterol, and apolipoprotein B among statin-treated US adults: National Health and Nutrition Examination Survey 2009-2010.
    Wong ND; Chuang J; Zhao Y; Rosenblit PD
    J Clin Lipidol; 2015; 9(4):525-32. PubMed ID: 26228670
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relation between low-density lipoprotein cholesterol/apolipoprotein B ratio and triglyceride-rich lipoproteins in patients with coronary artery disease and type 2 diabetes mellitus: a cross-sectional study.
    Tani S; Yagi T; Atsumi W; Kawauchi K; Matsuo R; Hirayama A
    Cardiovasc Diabetol; 2017 Oct; 16(1):123. PubMed ID: 28969633
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Beyond low-density lipoprotein cholesterol: defining the role of low-density lipoprotein heterogeneity in coronary artery disease.
    Mudd JO; Borlaug BA; Johnston PV; Kral BG; Rouf R; Blumenthal RS; Kwiterovich PO
    J Am Coll Cardiol; 2007 Oct; 50(18):1735-41. PubMed ID: 17964036
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic contributions to quantitative lipoprotein traits associated with coronary artery disease: analysis of a large pedigree from the Bogalusa Heart Study.
    Heiba IM; DeMeester CA; Xia YR; Diep A; George VT; Amos CI; Srinivasan SR; Berenson GS; Elston RC; Lusis AJ
    Am J Med Genet; 1993 Nov; 47(6):875-83. PubMed ID: 8279486
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Age and Cardiovascular Risk Attributable to Apolipoprotein B, Low-Density Lipoprotein Cholesterol or Non-High-Density Lipoprotein Cholesterol.
    Sniderman AD; Islam S; McQueen M; Pencina M; Furberg CD; Thanassoulis G; Yusuf S
    J Am Heart Assoc; 2016 Oct; 5(10):. PubMed ID: 27737874
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma apolipoprotein B and VLDL-, LDL-, and HDL-cholesterol as risk factors in the development of coronary artery disease in male patients examined by angiography.
    Whayne TF; Alaupovic P; Curry MD; Lee ET; Anderson PS; Schechter E
    Atherosclerosis; 1981 Jun; 39(3):411-24. PubMed ID: 6942843
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum calcium and phosphorus associate with the occurrence and severity of angiographically documented coronary heart disease, possibly through correlation with atherogenic (apo)lipoproteins.
    Rasouli M; Kiasari AM
    Clin Chem Lab Med; 2006; 44(1):43-50. PubMed ID: 16375584
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gender-specific association of coronary artery calcium and lipoprotein parameters: the Heinz Nixdorf Recall Study.
    Erbel R; Lehmann N; Churzidse S; Möhlenkamp S; Moebus S; Mahabadi AA; Schmermund A; Stang A; Dragano N; Grönemeyer D; Seibel R; Kälsch H; Bauer M; Bröcker-Preuss M; Mann K; Jöckel KH;
    Atherosclerosis; 2013 Aug; 229(2):531-40. PubMed ID: 23701995
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Apolipoprotein B is associated with carotid atherosclerosis progression independent of individual cholesterol measures in a 9-year prospective study of Multi-Ethnic Study of Atherosclerosis participants.
    Steffen BT; Guan W; Remaley AT; Stein JH; Tattersall MC; Kaufman J; Tsai MY
    J Clin Lipidol; 2017; 11(5):1181-1191.e1. PubMed ID: 28826575
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.